Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedJul 21, 2024
DataAggregated Company Financials
Companies12
  • 7D5.3%
  • 3M32.6%
  • 1Y50.9%
  • YTD28.5%

AddLife is up 6.1%, leading the way for the Life Sciences industry, which has gained 5.3%. In the last 12 months, the industry was up 51%. Looking forward, earnings are forecast to grow by 47% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 21 Jul 2024SEK 48.6bSEK 16.6b-SEK 1,138,220,510.0061.7x-42.7x2.9x
Tue, 18 Jun 2024SEK 42.8bSEK 16.3b-SEK 1,188,686,510.0057.4x-36x2.6x
Thu, 16 May 2024SEK 41.9bSEK 16.3b-SEK 1,157,635,671.0036x-36.2x2.6x
Sat, 13 Apr 2024SEK 38.5bSEK 16.0b-SEK 1,122,792,213.0035.5x-34.3x2.4x
Mon, 11 Mar 2024SEK 39.7bSEK 16.0b-SEK 1,123,139,210.0040.2x-35.3x2.5x
Wed, 07 Feb 2024SEK 39.5bSEK 15.8b-SEK 1,473,823,683.0057.1x-26.8x2.5x
Fri, 05 Jan 2024SEK 36.6bSEK 15.5b-SEK 1,393,723,683.0043.9x-26.2x2.4x
Sun, 03 Dec 2023SEK 34.6bSEK 15.5b-SEK 1,393,723,683.0040.6x-24.8x2.2x
Tue, 31 Oct 2023SEK 27.5bSEK 15.4b-SEK 1,255,923,711.0032x-21.9x1.8x
Thu, 28 Sep 2023SEK 26.0bSEK 15.1b-SEK 1,134,516,711.0037.6x-22.9x1.7x
Sat, 26 Aug 2023SEK 30.0bSEK 15.1b-SEK 1,137,904,038.0041.6x-26.4x2x
Mon, 24 Jul 2023SEK 32.2bSEK 14.9b-SEK 239,671,038.0047.8x-134.4x2.2x
Wed, 21 Jun 2023SEK 36.9bSEK 14.6b-SEK 172,476,038.0038.7x-214.2x2.5x
Fri, 19 May 2023SEK 39.3bSEK 14.6b-SEK 174,259,792.0039x-225.4x2.7x
Sun, 16 Apr 2023SEK 33.3bSEK 14.6b-SEK 57,449,459.0033.3x-579.1x2.3x
Tue, 14 Mar 2023SEK 34.1bSEK 14.6b-SEK 57,185,459.0030.5x-596.8x2.3x
Thu, 09 Feb 2023SEK 42.5bSEK 14.3bSEK 827.3m40x51.3x3x
Sat, 07 Jan 2023SEK 38.6bSEK 14.2bSEK 943.9m40.6x40.9x2.7x
Mon, 05 Dec 2022SEK 38.8bSEK 14.1bSEK 944.3m42.4x41.1x2.7x
Wed, 02 Nov 2022SEK 34.2bSEK 13.8bSEK 743.0m52.2x46.1x2.5x
Fri, 30 Sep 2022SEK 31.3bSEK 13.5bSEK 750.9m45.4x41.7x2.3x
Sun, 28 Aug 2022SEK 39.0bSEK 13.5bSEK 746.2m54.7x52.3x2.9x
Tue, 26 Jul 2022SEK 44.6bSEK 13.1bSEK 662.4m43.4x67.4x3.4x
Thu, 23 Jun 2022SEK 43.6bSEK 13.2bSEK 753.4m39.9x57.9x3.3x
Sat, 21 May 2022SEK 55.5bSEK 13.2bSEK 753.3m47.7x73.6x4.2x
Mon, 18 Apr 2022SEK 65.4bSEK 11.8bSEK 732.3m54.3x89.3x5.5x
Wed, 16 Mar 2022SEK 56.5bSEK 11.8bSEK 745.4m49.4x75.8x4.8x
Fri, 11 Feb 2022SEK 55.9bSEK 11.4bSEK 762.7m47.1x73.4x4.9x
Sun, 09 Jan 2022SEK 75.4bSEK 10.8bSEK 786.3m51.5x95.9x7x
Tue, 07 Dec 2021SEK 76.8bSEK 10.8bSEK 787.8m48.1x97.5x7.1x
Thu, 04 Nov 2021SEK 98.8bSEK 10.5bSEK 892.5m58.6x110.6x9.4x
Sat, 02 Oct 2021SEK 91.6bSEK 9.9bSEK 853.6m52.2x107.3x9.3x
Mon, 30 Aug 2021SEK 100.1bSEK 9.9bSEK 853.6m58.2x117.3x10.1x
Price to Earnings Ratio

106.8x


Total Market Cap: SEK 91.2bTotal Earnings: SEK 853.6mTotal Revenue: SEK 9.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -26.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.84%
Healthcare0.80%
Life Sciences5.29%
Clinical Research and Equipment5.29%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 152.706.1%
+SEK 1.1b		82.7%PE157.7x
BIOT BiotageSEK 185.306.6%
+SEK 920.1m		38.8%PE59.1x
MCAP MedCapSEK 593.005.7%
+SEK 473.8m		125.9%PE43.2x
MAGLE Magle Chemoswed HoldingSEK 44.409.9%
+SEK 43.2m		26.1%PE62.3x
AROC AroCellSEK 0.5017.4%
+SEK 17.0m		-1.2%PS2.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOT

SEK 185.30

Biotage

7D

6.6%

1Y

38.8%

MAGLE

SEK 44.40

Magle Chemoswed Holding

7D

9.9%

1Y

26.1%

ALIF B

SEK 152.70

AddLife

7D

6.1%

1Y

82.7%

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Jul 18
Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

BICO

SEK 45.04

BICO Group

7D

-0.3%

1Y

-7.5%

MCAP

SEK 593.00

MedCap

7D

5.7%

1Y

125.9%

CLINE B

SEK 0.074

Cline Scientific

7D

23.3%

1Y

-74.4%

GENO

SEK 28.90

Genovis AB (publ.)

7D

-3.0%

1Y

-32.5%

PEXA B

SEK 0.42

PExA

7D

4.0%

1Y

-19.1%

AROC

SEK 0.50

AroCell

7D

17.4%

1Y

-1.2%

PRO

SEK 34.20

Promimic

7D

-2.6%

1Y

12.9%

LEVBIO

SEK 0.34

Level Bio

7D

-2.9%

1Y

-45.0%